STOCK TITAN

Invesco discloses 5% ADMA Biologics (ADMA) stake held for clients

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Invesco Ltd. filed an amended Schedule 13G reporting beneficial ownership of 11,785,202 shares of ADMA Biologics Inc common stock, representing 5.0% of the class as of 12/31/2025. Invesco reports sole voting power over 11,085,226 shares and sole dispositive power over 11,785,202 shares.

The shares are held of record by clients of Invesco’s investment adviser subsidiaries, including Invesco Advisers, Inc., Invesco Asset Management Limited, and Invesco Capital Management LLC, with no single individual having more than 5% economic ownership. Invesco certifies the position is held in the ordinary course of business and not to influence control of ADMA.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Invesco Ltd.
Signature:Robert R. Leveille
Name/Title:Global Head of Compliance
Date:02/12/2026

FAQ

What percentage of ADMA (ADMA) does Invesco Ltd. report owning?

Invesco Ltd. reports beneficial ownership of 5.0% of ADMA Biologics’ common stock. This stake corresponds to 11,785,202 shares held as of December 31, 2025, according to the amended Schedule 13G filing.

How many ADMA (ADMA) shares does Invesco Ltd. control the voting for?

Invesco Ltd. reports sole voting power over 11,085,226 ADMA shares. It reports no shared voting power, indicating voting authority is held solely through its controlled investment adviser entities for these shares.

Who actually holds the ADMA (ADMA) shares reported by Invesco Ltd.?

The 11,785,202 ADMA shares are held of record by clients of Invesco’s investment advisers. Invesco files as a parent holding company, and no individual client has more than 5% economic ownership of ADMA’s common stock.

Is Invesco Ltd. seeking to influence control of ADMA (ADMA) with this stake?

Invesco certifies the ADMA shares were acquired and are held in the ordinary course of business. It states they were not acquired for the purpose of changing or influencing control of ADMA Biologics.

Which Invesco subsidiaries are associated with the ADMA (ADMA) holdings?

The filing identifies Invesco Advisers, Inc., Invesco Asset Management Limited, and Invesco Capital Management LLC as the relevant subsidiaries. These investment adviser entities hold ADMA shares on behalf of their clients.

What type of reporting person is Invesco Ltd. in the ADMA (ADMA) filing?

Invesco Ltd. is classified as a parent holding company or control person, indicated by the type code HC. The company is organized in Bermuda and files on behalf of its investment adviser subsidiaries.
Adma Biologics

NASDAQ:ADMA

ADMA Rankings

ADMA Latest News

ADMA Latest SEC Filings

ADMA Stock Data

3.87B
228.63M
2.57%
90.71%
6.28%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
RAMSEY